A Phase 1, Open-label, Dose-escalation trial of CD33xCD3 Bispecific Antibody inPediatric patients with Relapsed or Refractory Acute Myeloid Leukemia

Project: Research project


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.


Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science